Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-02 @ 4:10 AM
Study NCT ID:
NCT02220933
Status:
UNKNOWN
Last Update Posted:
2017-03-27
First Post:
2014-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of MD1003 in Spinal Progressive Multiple Sclerosis
Sponsor:
MedDay Pharmaceuticals SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01
Completion Date Type:
ESTIMATED
First Submit Date:
2014-08-18
First Submit QC Date:
None
Study First Post Date:
2014-08-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-23
Last Update Post Date:
2017-03-27
Last Update Post Date Type:
ACTUAL